Summary
We have examined hormonal and metabolic responses to insulin-induced hypoglycaemia in 10 Type 2 (non-insulin-dependent) diabetic patients treated with tablets and 10 age, sex and weight matched control subjects. Diabetic patients were under 110% ideal body weight, had no autonomie neuropathy and were well controlled (HbA1, 7.1±0.2%). After the diabetic patients were kept euglycaemic by an overnight insulin infusion, hypoglycaemia was induced in both groups by intravenous insulin at 30 mU·m–2·min−1 for 60 min and counterregulatory responses measured for 150 min. There were no significant differences between diabetic patients and control subjects in the rate of fall (3.3±0.3 vs 4.0±0.3 mmol·1−1·h−1), nadir (2.4±0.2 vs 2.3±0.1 mmol/l) and rate of recovery (0.027±0.002 vs 0.030±0.003 mmol·1−1·min−1) of blood glucose. Increments of glucagon (60.5±5.7 vs 70±9.2 ng/l) and adrenaline (1.22±0.31 vs 1.45±0.31 nmol/l) were similar in both groups. When tested using this model, patients with Type 2 diabetes, without microvascular complications and taking oral hypoglycaemic agents show no impairment of the endocrine response and blood glucose recovery following hypoglycaemia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH (1973) Lack of glucagon response to hypoglycaemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182: 171–173
Bolli G, De Feo P, Compagnucci P, Cartechini MG, Angeletti G, Santeusanio F, Brunetti P, Gerich JE (1983) Abnormal glucose counterregulation in insulin-dependent diabetes mellitus: interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion. Diabetes 32: 134–141
Popp DA, Shah SD, Cryer PE (1982) Role of epinephrine mediated beta adrenergic mechanisms in hypoglycemic glucose counterregulation and posthypoglycemic hyperglycemia in IDDM. J Clin Invest 69: 315–326
Boden G, Reichard GA, Hoeldtke RD, Rezvani I, Owen OE (1981) Severe insulin-induced hypoglycemia associated with deficiencies in the release of counterregulatory hormones. N Engl J Med 305: 1200–1205
White NH, Skor DA, Cryer PE, Levandoski LA, Bier DM, Santiago JV (1983) Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med 308: 485–491
Multicentre Study (1983) UK prospective study of therapies of maturity onset diabetes. 1. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight. Diabetologia 24: 404–411
Boden G, Soriano M, Hoeldtke RD, Owen OE (1983) Counterregulatory hormone release and glucose recovery after hypoglycemia in non insulin-dependent diabetic patients. Diabetes 32: 1055–1059
Polonsky KS, Herold KC, Gilden JL, Bergenstal RM, Fang VS, Moosa AR, Jaspan JB (1984) Glucose counterregulation in patients after pancreatectomy: comparison with other clinical forms of diabetes. Diabetes 33: 1112–1119
Bolli GB, Tsalikian E, Haymond MW, Cryer PE, Gerich JE (1984) Defective glucose counterregulation after subcutaneous insulin in noninsulin-dependent diabetes mellitus. J Clin Invest 73: 1532–1541
Bennett T (1983) Physiological investigation of diabetic autonomie failure. In: Bannister R (ed) Autonomie failure. A textbook of clinical disorders of the autonomie nervous system. Oxford University Press, Oxford, pp 403–436
Bolli GB, DeFeo P, De Cosmo S, Perriello G, Ventura MM, Massa Benedetti M, Santeusanio F, Gerich JE, Brunetti P (1984) A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes mellitus. Diabetes 33: 732–737
Lloyd B, Burin J, Smythe P, Alberti KGMM (1978) Enzymic flourimetric continuous-flow assays for blood glucose, lactate, alanine, glycerol and 3-hydroxybutyrate. Clin Chem 24: 1724–1729
Stout RW, Henry RW, Buchanan KD (1976) Triglyceride metabolism in acute starvation: the role of secretin and glucagon. Eur J Clin Invest 6: 179–185
O'Hare MMT, Daly JG, Buchanan KD (1983) Radioimmunoassay for pancreatic polypeptide, and it's age-related changes in concentration. Clin Chem 29: 1923–1927
Hales CN, Randle PJ (1963) Immunoassay of insulin. Biochem J 88: 137–146
Macdonald IA, Lake DM (1985) An improved technique for extracting catecholamines from body fluids. J Neurosci Methods 13: 239–248
Heding LG (1975) Radioimmunological determinations of human C-peptide in serum. Diabetologia 11: 541–554
Ambler J, Walker G, Janik B (1983) Measurement of glycosylated haemoglobin on cellulose acetate membrane. Clin Chem 29: 240–243
Genstat (1980) A General Statistical Program. Rothamstead Experimental Station. Numerical Algorithms Group Ltd, Oxford
Reynolds C, Molnar GD, Horwitz DL, Rubenstein AH, Taylor WF, Jiang NS (1977) Abnormalities of endogenous glucagon and insulin in unstable diabetes. Diabetes 26: 36–45
Campbell LV, Kraegen EW, Meler H, Lazarus L (1979) Hormonal responses to insulin infusion in diabetes mellitus. Diabetologia 16: 359–364
Levitt NS, Vinik AI, Sive AA, Child P, Jackson WPU (1979) Studies on plasma glucagon concentration in maturity-onset diabetics with autonomic neuropathy. Diabetes 28: 1015–1021
Cryer PE, Gerich JE (1985) Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. N Engl J Med 313: 232–241
Campbell LV, Kraegen EW, Lazarus L (1977) Defective blood glucose counter-regulation in diabetics is a selective form of autonomie neuropathy. Br Med J 2: 1527–1529
Maher TD, Tanenberg RJ, Greenberg BZ, Hoffman JE, Doe RP, Goetz FC (1977) Lack of glucagon response to hypoglycaemia in diabetic autonomie neuropathy. Diabetes 26: 196–200
Samols E, Weir G, Bonner-Weir S (1983) Intra-islet insulin-glucagon-somatostatin relationships. In: Lefebvre PJ (ed) Handbook of Pharmacology. Glucagon II, Springer, Berlin Heidelberg New York, pp 133–173
Unger RH (1983) Insulin-glucagon relationships in the defence against hypoglycaemia. Diabetes 32: 575–583
Bolli G, De Feo P, Perriello G, De Cosmo S, Compagnucci P, Santeusanio F, Brunetti P, Unger RH (1984) Mechanisms of glucagon secretion during insulin-induced hypoglycaemia in man. Role of the beta cell and arterial hyperinsulinemia. J Clin Invest 73: 917–922
Buchanan KD, Mawhinney WAA (1973) Glucagon release from isolated pancreas in streptozotocin treated rats. Diabetes 22: 797–800
Samols E, Harrison J (1976) Intraislet negative insulin/glucagon feedback. Metabolism 25 (Suppl 1): 1443–1447
Berk MA, Clutter WE, Skor D, Shah SD, Gingerich RP, Parvin CA, Cryer PE (1985) Enhanced glycemie responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. J Clin Invest 75: 1842–1851
Levitt NS, Vinik AI, Sive AA, Van Tonder S, Lund A (1980) Impaired pancreatic polypeptide responses to insulin induced hypoglycaemia in diabetic autonomie neuropathy. J Clin Endocrinol Metab 50: 445–449
Gray DE, Lickley HLA, Vranic M (1980) Physiologic effects of epinephrine on glucose turnover and plasma free fatty acid concentrations mediated independently of glucagon. Diabetes 29: 600–608
Schwartz TW (1983) Pancreatic polypeptide: a hormone under vagal control. Gastroenterology 85: 1411–1425
Sive AA, Vinik AI, Levitt N, Van Tonder S (1980) Adrenergic modulation of human pancreatic polypeptide (hPP) release. Gastroenterology 79: 665–672
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Heller, S.R., Macdonald, I.A. & Tattersall, R.B. Counterregulation in Type 2 (non-insulin-dependent) diabetes mellitus. Normal endocrine and glycaemic responses, up to ten years after diagnosis. Diabetologia 30, 924–929 (1987). https://doi.org/10.1007/BF00295875
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00295875